IIPR Stock Analysis: Innovative Industrial | NYSE

REIT - Industrial | NYSE, USA | Market Cap: 1.664m USD | 12M Return: 23.6% | US45781V1017 | Charts, Fundamentals & Technical Analysis

Industrial Properties, Life Science Real Estate, REIT, Cannabis Facilities
Total Rating 39
Safety 38
Buy Signal -0.19
REIT - Industrial
Industry Rotation: -11.0
Market Cap: 1.66B
Avg Turnover: 17.8M
Risk 3d forecast
Volatility37.3%
VaR 5th Pctl6.01%
VaR vs Median-1.84%
Reward TTM
Sharpe Ratio0.62
Rel. Str. IBD64.2
Rel. Str. Peer Group82.1
Character TTM
Beta0.169
Beta Downside0.533
Hurst Exponent0.460
Drawdowns 3y
Max DD62.92%
CAGR/Max DD0.00
CAGR/Mean DD0.01
EPS (Earnings per Share) EPS (Earnings per Share) of IIPR over the last years for every Quarter: "2021-06": 1.17, "2021-09": 1.2, "2021-12": 1.14, "2022-03": 1.32, "2022-06": 1.42, "2022-09": 1.32, "2022-12": 1.33, "2023-03": 1.43, "2023-06": 1.44, "2023-09": 1.45, "2023-12": 1.45, "2024-03": 1.36, "2024-06": 1.44, "2024-09": 1.37, "2024-12": 1.36, "2025-03": 1.03, "2025-06": 0.86, "2025-09": 0.97, "2025-12": 1.06, "2026-03": 1.04, "2026-06": 1.83,
EPS CAGR: -12.80%
EPS Trend: -82.3%
Last SUE: 1.53
Qual. Beats: 1
Revenue Revenue of IIPR over the last years for every Quarter: 2021-06: 48.867, 2021-09: 53.856, 2021-12: 58.943, 2022-03: 64.504, 2022-06: 70.511, 2022-09: 70.883, 2022-12: 70.461, 2023-03: 76.067, 2023-06: 76.457, 2023-09: 77.826, 2023-12: 79.156, 2024-03: 75.454, 2024-06: 79.793, 2024-09: 76.526, 2024-12: 76.744, 2025-03: 71.722, 2025-06: 62.891, 2025-09: 64.685, 2025-12: 66.657, 2026-03: 68.996, 2026-06: 63.315,
Rev. CAGR: -6.51%
Rev. Trend: -86.6%
Last SUE: -3.66
Qual. Beats: -1

Warnings

Below Avwap Earnings

Tailwinds

No distinct edge detected

Seasonality 9.7 years of data

Jan -1.5% 9
Feb +0.4% 18
Mar -2.5% 20
Apr -1.0% 22
May +0.9% 9
Jun +3.5% 21
Jul -5.9% 9
Aug +10.0% 36
Sep -0.4% 2
Oct -7.0% 29
Nov +5.3% 0
Dec -0.4% 8

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: IIPR Innovative Industrial

Innovative Industrial Properties, Inc. (IIPR) is a Maryland-incorporated REIT headquartered in San Diego, California. The company was formed in June 2016 and listed on the NYSE in December 2016. IIPR focuses on the acquisition, ownership, and management of specialized industrial properties and life science real estate.

As a REIT, IIPR operates under the U.S. tax framework that requires such entities to distribute the majority of their taxable income as dividends to shareholders in exchange for pass-through tax treatment. IIPRs portfolio is concentrated in regulated-tenant industrial facilities, including properties leased to state-licensed cannabis operators, which distinguishes it within the broader Industrial REITs sub-industry.

Headlines to Watch Out For
  • Cannabis tenant defaults pressure FFO and dividend coverage
  • Federal cannabis rescheduling unlocks institutional investor demand
  • Rising interest rates compress cap rate spreads on acquisitions
Piotroski VR-10 (Strict) 4.5
Net Income: 137.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.42 > 1.0
NWC/Revenue: 27.90% < 20% (prev 0.11%; Δ 27.79% < -1%)
CFO/TA 0.08 > 3% & CFO 196.4m > Net Income 137.8m
Net Debt (405.3m) to EBITDA (238.4m): 1.70 < 3
Current Ratio: 1.36 > 1.5 & < 3
Outstanding Shares: last quarter (30.0m) vs 12m ago 5.91% < -2%
Gross Margin: 74.29% > 18% (prev 89.88%; Δ -15.58% > 0.5%)
Asset Turnover: 10.79% > 50% (prev 12.49%; Δ -1.70% > 0%)
Interest Coverage Ratio: 6.29 > 6 (EBIT TTM 163.8m / Interest Expense TTM 26.0m)
Altman Z'' 2.86
A: 0.03 (Total Current Assets 276.5m - Total Current Liabilities 203.0m) / Total Assets 2.58b
B: -0.14 (Retained Earnings -349.7m / Total Assets 2.58b)
C: 0.07 (EBIT TTM 163.8m / Avg Total Assets 2.44b)
D: 2.54 (Book Value of Equity 1.85b / Total Liabilities 730.0m)
Altman-Z'' = 2.86 = A
Beneish M -1.77
DSRI: 3.0 (Receivables 71.8m/22.8m, Revenue 263.7m/287.9m)
GMI: 1.21 (GM 89.88% / 74.29%)
AQI: 0.13 (AQ_t 0.12 / AQ_t-1 0.95)
SGI: 0.92 (Revenue 263.7m / 287.9m)
TATA: -0.02 (NI 137.8m - CFO 196.4m) / TA 2.58b)
Beneish M = -1.77 (Cap -4..+1) = CCC
What is the price of IIPR shares?

As of August 18, 2026, the stock is trading at USD 55.80 with a total of 286,365 shares traded. Over the past week, the price has changed by -2.79%, over one month by -13.45%, over three months by +5.40% and over the past year by +23.60%.

Current recommended Stop Loss: 53.60 (which is 3.9% or 1.3 ATR below the current price).

Is IIPR a buy, sell or hold?

Innovative Industrial has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold IIPR.

  • StrongBuy: 1
  • Buy: 1
  • Hold: 2
  • Sell: 1
  • StrongSell: 1

What are the forecasts/targets for the IIPR price?
Analysts Target Price 63.3 13.4%
Innovative Industrial (IIPR) - Fundamental Data Overview as of 12 August 2026
Market Cap USD = 1.66b (1.66b USD * 1.0 USD.USD)
P/E Trailing = 13.38
P/E Forward = 13.21
P/S = 6.3126
P/B = 0.9958
Revenue TTM = 263.7m USD
EBIT TTM = 163.8m USD
EBITDA TTM = 238.4m USD
Long Term Debt = 516.5m USD (from longTermDebt, last quarter)
Short Term Debt = 92.5m USD (from shortTermDebt, last quarter)
Debt = 610.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 998k
Net Debt = 405.3m USD (calculated: Debt 610.0m - CCE 204.7m)
Enterprise Value = 2.07b USD (1.66b + Debt 610.0m - CCE 204.7m)
Interest Coverage Ratio = 6.29 (Ebit TTM 163.8m / Interest Expense TTM 26.0m)
EV/FCF = 10.54x (Enterprise Value 2.07b / FCF TTM 196.4m)
FCF Yield = 9.49% (FCF TTM 196.4m / Enterprise Value 2.07b)
FCF Margin = 74.51% (FCF TTM 196.4m / Revenue TTM 263.7m)
Net Margin = 52.27% (Net Income TTM 137.8m / Revenue TTM 263.7m)
Gross Margin = 74.29% ((Revenue TTM 263.7m - Cost of Revenue TTM 67.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 35.15%)
Tobins Q-Ratio = 0.80 (Enterprise Value 2.07b / Total Assets 2.58b)
Interest Expense / Debt = 4.27% (Interest Expense 26.0m / Debt 610.0m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 129.4m (EBIT 163.8m * (1 - 21.00%))
Current Ratio = 1.36 (Total Current Assets 276.5m / Total Current Liabilities 203.0m)
Debt / Equity = 0.33 (Debt 610.0m / totalStockholderEquity, last quarter 1.85b)
Debt / EBITDA = 1.70 (Net Debt 405.3m / EBITDA 238.4m)
Debt / FCF = 2.06 (Net Debt 405.3m / FCF TTM 196.4m)
Total Stockholder Equity = 1.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.64% (Net Income 137.8m / Total Assets 2.58b)
RoE = 7.39% (Net Income TTM 137.8m / Total Stockholder Equity 1.86b)
RoCE = 6.88% (EBIT 163.8m / Capital Employed (Equity 1.86b + L.T.Debt 516.5m))
RoIC = 5.27% (NOPAT 129.4m / Invested Capital 2.46b)
WACC = 5.72% (E(1.66b)/V(2.27b) * Re(6.58%) + D(610.0m)/V(2.27b) * Rd(4.27%) * (1-Tc(0.21)))
Discount Rate = 6.58% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 39.18 | Cagr: 2.35%
[DCF] Terminal Value 74.64% ; FCFF base≈201.1m ; Y1≈192.4m ; Y5≈185.1m
[DCF] Fair Price = 86.35 (EV 2.91b - Net Debt 405.3m = Equity 2.50b / Shares 29.0m; r=8.35% [WACC [floored]]; 5y FCF grow -5.64% → 2.50% )
EPS Correlation: -82.30 | EPS CAGR: -12.80% | SUE: 1.53 | # QB: 1
Revenue Correlation: -86.62 | Revenue CAGR: -6.51% | SUE: -3.66 | # QB: -1
EPS current Quarter (2026-09-30): EPS=1.08 | Chg30d=-1.37% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=4.27 | Chg30d=-0.23% | Revisions=-25% | GrowthEPS=+8.6% | GrowthRev=-1.0%
EPS next Year (2027-12-31): EPS=4.79 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+12.2% | GrowthRev=+4.0%